NDC 63323-262-09 - Heparin Sodium

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 63323-262
Requested NDC: 63323-262-09
Package NDCs from labels: 63323-262-03, 63323-262-06, 63323-262-01, 63323-262-55, 63323-262-09, 63323-262-26, 63323-262-11, 63323-262-36
Manufacturer: Cardinal Health 107, LLC
Effective date: 2026-05-12
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Heparin Sodium - Cardinal Health 107, LLC	Cardinal Health 107, LLC	2026-05-12	HUMAN PRESCRIPTION DRUG LABEL
Heparin Sodium - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2026-04-30	HUMAN PRESCRIPTION DRUG LABEL
Heparin Sodium - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2025-11-28	HUMAN PRESCRIPTION DRUG LABEL
Heparin Sodium - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2025-11-27	HUMAN PRESCRIPTION DRUG LABEL
Heparin Sodium - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2021-09-01	HUMAN PRESCRIPTION DRUG LABEL
Heparin Sodium - Cardinal Health	Cardinal Health	2020-07-10	HUMAN PRESCRIPTION DRUG LABEL
Heparin Sodium - Cardinal Health	Cardinal Health	2020-07-09	HUMAN PRESCRIPTION DRUG LABEL
Heparin Sodium - General Injectables & Vaccines, Inc	General Injectables & Vaccines, Inc	2017-01-16	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63323-262-01	Heparin Sodium	25 in 1 TRAY	INJECTION, SOLUTION	25	13
63323-262-01	Heparin Sodium	1 mL in 1 VIAL	INJECTION, SOLUTION	1	13
63323-262-09	Heparin Sodium	1 mL in 1 VIAL	INJECTION, SOLUTION	1	8
63323-262-26	Heparin Sodium	25 in 1 TRAY	INJECTION, SOLUTION	25	8
63323-262-55	Heparin Sodium	1 mL in 1 VIAL	INJECTION, SOLUTION	1	8
63323-262-55	Heparin Sodium	25 in 1 TRAY	INJECTION, SOLUTION	25	8
63323-262-03	Heparin Sodium	1 mL in 1 VIAL	INJECTION, SOLUTION	1	6
63323-262-06	Heparin Sodium	25 in 1 TRAY	INJECTION, SOLUTION	25	6
63323-262-11	Heparin Sodium	1 mL in 1 VIAL	INJECTION, SOLUTION	1	2
63323-262-36	Heparin Sodium	25 in 1 TRAY	INJECTION, SOLUTION	25	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63323-262	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	12	Current NDC, Legacy NDC, 2 package rows	20241017_d55b4a63-0c04-4874-b74f-9e9b9e8b008c.zip
63323-262	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	7	Current NDC, Legacy NDC, 4 package rows	20211003_ed937dd2-8fab-4875-a1e8-627b71ccb7fb.zip
63323-262	HEPARIN SODIUM (HEPARIN SODIUM) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ]	4	Current NDC, Legacy NDC, 2 package rows	20220129_2a173253-dfdc-4d9d-8dee-b9c13e6fa9f5.zip
63323-262	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	2	Current NDC, Legacy NDC, 2 package rows	20211003_3facd525-b9ad-46d0-b63e-f13a5f6d591d.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63323-262-01	ML - Milliliter	63323-262	7b9d701f-5fd7-4353-8df3-d197e4fc1ee4	1	2012-07-24
63323-262-03	ML - Milliliter	63323-262	f47af711-f4c6-4071-ad70-82e25c4ffa0f	1	2020-03-10
63323-262-06	ML - Milliliter	63323-262	4f065a22-1ca0-4ca9-ad15-d6812f73385f	1	2020-03-10
63323-262-09	ML - Milliliter	63323-262	7e5a48ff-ca18-41e3-98f5-3d00ee5be018	1	2020-06-05
63323-262-11	ML - Milliliter	63323-262	594d7a8c-4520-4dbd-ad09-ca7cde371694	1	2020-05-08
63323-262-26	ML - Milliliter	63323-262	90c4b495-6153-4a3d-a233-82c90d5158d5	1	2020-06-05
63323-262-36	ML - Milliliter	63323-262	8275de90-fdea-429b-a542-823990affb0e	1	2020-05-08
63323-262-55	ML - Milliliter	63323-262	e67b6b86-9520-4892-92f5-53acf3e7ec46	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HEPARIN SODIUM	ACTIVE INGREDIENT	ZZ45AB24CA	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	14
HEPARIN	ACTIVE MOIETY	T2410KM04A	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	14
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	14
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	14
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	14
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	14
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	14
HEPARIN SODIUM	ACTIVE INGREDIENT	ZZ45AB24CA	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
HEPARIN	ACTIVE MOIETY	T2410KM04A	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	9
HEPARIN SODIUM	ACTIVE INGREDIENT	ZZ45AB24CA	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	4
HEPARIN SODIUM	ACTIVE INGREDIENT	ZZ45AB24CA	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	4
HEPARIN	ACTIVE MOIETY	T2410KM04A	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	4
HEPARIN	ACTIVE MOIETY	T2410KM04A	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	4
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	4
HYDROCHLORIC ACID	INACTIVE INGREDIENT	QTT17582CB	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	4
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	4
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	4
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	4
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	4
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	4
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	4
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	HEPARIN SODIUM INJECTION, SOLUTION [CARDINAL HEALTH]	4
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	HEPARIN SODIUM INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]	4
Heparin Sodium	ACTIVE INGREDIENT	ZZ45AB24CA	HEPARIN SODIUM INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC]	1
Heparin	ACTIVE MOIETY	T2410KM04A	HEPARIN SODIUM INJECTION, SOLUTION [GENERAL INJECTABLES & VACCINES, INC]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 58 · 1,155 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lymph Tonic II	ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA	BioActive Nutritional, Inc.	0e3265b0-b210-4a4c-80d2-8a9712981d4e	2026-09-17	Warnings	Exact identifier unii: 451W47IQ8X
Saline	NASAL	Raritan Pharmaceuiticals Inc	4b178e4e-a10f-4b75-8140-1f7548e203ad	2026-09-09	Warnings	Exact identifier unii: 451W47IQ8X
Thyroid Support	CALCAREA CARBONICA, CALCAREA IODATA, CAUSTICUM, FERRUM IODATUM, FUCUS VESICULOSUS, KALI IODATUM, NATRUM MURIATICUM, THYROIDINUM (BOVINE)	NaturalCare	07b4e0ed-2b00-4d0a-ad8f-fc6deff15325	2026-09-08	Warnings	Exact identifier unii: 451W47IQ8X
Psoriasis Control	CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE	Forces of Nature	2db33771-0bb9-49f8-84fa-dddc28e4ba26	2026-09-04	Warnings	Exact identifier unii: 451W47IQ8X
KROGER Saline	NASAL	KROGER COMPANY	c84b242b-f46e-4ea8-a3c1-109a47644646	2026-09-02	Warnings	Exact identifier unii: 451W47IQ8X
Adrenal Support	ADRENALINUM, ARGENTUM NITRICUM, BERBERIS VULGARIS, NATRUM MURIATICUM, OLEUM MORRHUAE, PETROLEUM, VANADIUM	NaturalCare	31a5d522-15cd-432a-bf87-f721bcbe2e31	2026-09-02	Warnings	Exact identifier unii: 451W47IQ8X
Xtreme Saline Rinse Mix	SODIUM BICARBONATE, SODIUM CHLORIDE	Xtreme Personal Care Inc	776f417e-e443-4918-8c7a-1913b7dddcd4	2026-09-01	Warnings	Exact identifier unii: 451W47IQ8X
Nacl 0.9% Normal Saline Solution	SODIUM CHLORIDE	CHI FUNG TECHNOLOGY COMPANY	5a53c4c8-c9de-700c-e063-6394a90a3ab5	2026-08-31	Warnings	Exact identifier unii: 451W47IQ8X
BMNP Nat Mur	NATRUM MURIATICUM	Total Operations Management LLC DBA:Bestmade Natural Products Micro	5a57ccfd-ab6f-cb2c-e063-6394a90ae9e6	2026-08-31	Warnings	Exact identifier unii: 451W47IQ8X
Allergy Care	ADRENALINUM, RAGWEED, POLLEN (AMBROSIA ARTEMISIAEFOLIA), APIS MELLIFICA, ECHINACEA (ANGUSTIFOLIA), HISTAMINUM HYDROCHLORICUM, LEDUM PALUSTRE, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, SULPHUR	NaturalCare	f3ca7f5a-1448-4670-ac02-b47ffb6c5585	2026-08-27	Warnings	Exact identifier unii: 451W47IQ8X
KUGIG ALOE FOAMING INTIMATE WASH	INTIMATE CLEANSING FOAM	Hong Kong KangXing Centennial Management Limited	59f4d398-1186-a168-e063-6294a90ab44b	2026-08-26	Warnings	Exact identifier unii: 059QF0KO0R
Saline	SALINE NASAL SPRAY	Dynarex Corporation	3247ae7d-554f-baab-e063-6294a90aa3ec	2026-08-25	Warnings	Exact identifier unii: 451W47IQ8X
Electrolyte Plus	KALI MURIATICUM, L-ARGININE, L-CARNITINE, L-LEUCINE, L-ORNITHINE, L-VALINE, MAGNESIA MURIATICA, ASCORBICUM ACIDUM, BORAX, CHROMIUM OXYDATUM, FERRUM MURIATICUM, KALI CARBONICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NATRUM MURIATICUM, ZINCUM GLUCONICUM, CUPRUM METALLICUM, KALI PHOSPHORICUM, NICCOLUM METALLICUM, SELENIUM METALLICUM, VANADIUM METALLICUM, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, MANGANUM CARBONICUM	Deseret Biologicals, Inc.	e3564733-8b88-4753-9077-9d74004d8ec9	2026-08-25	Warnings	Exact identifier unii: 451W47IQ8X
Heparin Sodium	HEPARIN SODIUM	Hospira, Inc.	c8c4edd2-ee9e-4558-6b8c-b83adc242a0a	2026-08-25	Warnings, Adverse reactions	Exact identifier unii: ZZ45AB24CA
Sterile Water	WATER	REMEDYREPACK INC.	5dd5d148-6e23-41de-bff5-551b2aea9598	2026-08-24	Warnings, Adverse reactions	Exact identifier unii: 059QF0KO0R
Aging Eye Formula	CINERARIA MARITIMA, EYE (SUIS), CALCAREA FLUORICA, CAUSTICUM, PHOSPHORUS, SILICEA, ZINCUM METALLICUM, GERMANIUM METALLICUM, NATRUM MURIATICUM	Nutritional Specialties, Inc.	d5b44f79-5299-4b31-ba45-0e511cdbe17c	2026-08-24	Warnings	Exact identifier unii: 451W47IQ8X
0.9% Benzyl Alcohol Solution (Laboratory Use Only)	0.9% BENZYL ALCOHOL SOLUTION (LABORATORY USE ONLY)	Guangzhou Huanmei Cosmetics Co., Ltd	5976bde6-0999-ffc4-e063-6394a90aadcf	2026-08-20	Warnings	Exact identifier unii: LKG8494WBH
Bio Combination 28	SCHUESSLER SALTS	LDD Bioscience Private Limited	597caf33-5107-9dec-e063-6294a90a5fcd	2026-08-20	Warnings	Exact identifier unii: 451W47IQ8X
Sodium Chloride	SODIUM CHLORIDE	YYBA CORP	597f3347-647c-3545-e063-6294a90abab2	2026-08-20	Warnings	Exact identifier unii: 451W47IQ8X
Sodium Chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e88	2026-08-20	Warnings, Adverse reactions	Exact identifier unii: 451W47IQ8X

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.